[1]马丁.卵巢癌研究进展与规范化治疗[J].中国实用妇科与产科杂志,2021,37(6):601-604.
MA D.Progress in ovarian cancer research and standardized treatment[J].Chinese Journal of Practical Gynecology and Obstetrics,2021,37(6):601-604.
[2]YAMADA Y,MABUCHI S,KAWAHARA N,et al.Prognostic significance of tumor laterality in advanced ovarian cancer[J].Obstet Gynecol Sci,2021,64:524-531.
[3]LONG SL,LI YK,XIE YJ,et al.Neurite outgrowth inhibitor B receptor:A versatile receptor with multiple functions and actions[J].DNA Cell Biol,2017,36(12):1142-1150.
[4]LI YK,XIE YJ,WU DC,et al.Nogo B receptor in relevant carcinoma:Current achievements,challenges and aims (review)[J].Int J Oncol,2018,53(5):1827-1835.
[5]CAI H,SAIYIN H,LIU X,et al.Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma[J].Mol Oncol,2018,12(12):2042-2054.
[6]KAWAGUCHI N,TASHIRO K,TANIGUCHI K,et al.Nogo-B (Reticulon-4B) functions as a negative regulator of the apoptotic pathway through the interaction with c-FLIP in colorectal cancer cells[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(8):2600-2609.
[7]WANG H,YUNG MMH,NGAN HYS,et al.The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression[J].Int J Mol Sci,2021,22(12):6560.
[8]ZHANG N,CUI Y,LI Y,et al.A novel role of Nogo proteins:Regulating macrophages in inflammatory disease[J].Cell Mol Neurobiol,2021:1-10.doi:10.1007/s10571-021-01124-0.
[9]ZHAO X,WANG X,YOU Y,et al.Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization[J].Exp Cell Res,2020,391(1):111979.
[10]储慧慧,刘倩.卵巢癌临床治疗的研究进展[J].国际妇产科学杂志,2021,48(04):443-447,466.
CHU HH,LIU Q.Research progress in clinical treatment of ovarian cancer[J].Journal of Obstetrics and Gynecology,2012,48(04):443-447,466.
[11]江霞,赵长久.siRNA在卵巢癌靶向治疗中的研究进展[J].现代肿瘤医学,2021,29(9):1635-1638.
JIANG X,ZHAO CJ.Research progress of siRNA in targeted therapy of ovarian cancer[J].Modern Oncology,2021,29(9):1635-1638.
[12]KOMOHARA Y,FUJIWARA Y,OHNISHI TAKEYA M.Tumor-associated macrophages:Potential therapeutic targets for anti-cancer therapy[J].Adv Drug Deliv Rev,2016,99(Pt B):180-185.
[13]HWANG I,KIM JW,YLAYA K,et al.Tumor-associated macrophage,angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients[J].J Transl Med,2020,18(1):443.
[14]YUAN X,LI Y,ZHANG AZ,et al.Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma[J].Aging (Albany NY),2020,13(2):2049-2072.
[15]YAMAGUCHI T,FUSHIDA S,YAMAMOTO Y,et al.Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination[J].Gastric Cancer,2016,19(4):1052-1065.
[16]ZHANG M,HE Y,SUN X,et al.A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients[J].J Ovarian Res,2014,7:19.
[17]XIAO W,ZHOU S,XU H,et al.Nogo-B promotes the epithelial-mesenchymal transition in HeLa cervical cancer cells via Fibulin-5[J].Oncol Rep,2013,29(1):109-116.
[18]YU J,FERNNDEZ-HERNANDO C,SUAREZ Y,et al.Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair[J].Proc Natl Acad Sci USA,2009,106(41):17511-17516.
[19]ZHU Y,TONG Q,YE J,et al.Nogo-B facilitates LPS-mediated immune responses by up-regulation of TLR4-signaling in macrophage RAW264.7[J].Cell Physiol Biochem,2017,41(1):274-285.